课题基金 / 基金详情

Synthesis of Bio-Inorganic Tracers for Diagnostic Radiol

Synthesis of Bio-Inorganic Tracers for Diagnostic Radiol
放射诊断用生物无机示踪剂的合成
批准号:
7319241
负责人:
Terry M. Phillips
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Terry M. Phillips的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Molecular and cellular imaging is a rapidly developing field whose results have the potential to contribute to the successes of cellular therapies. The development and testing of novel tools, reagents, and methods to image specific molecular pathways in vivo, particularly those that are key targets in disease processes may further the understanding of the pathology. The intrinsic magnetic resonance image (MRI) contrast of tissues can be augmented by the use of contrast agents (CA) in both clinical and experimental settings. CA increases the 1/T-1 and 1/T-2, often referred to as the inner and outer sphere relaxation water in the case of in vivo MRI. Inner sphere relaxation is enhanced by increasing the primary water-metal interaction, while outer sphere relaxation is enhanced by increasing the primary water-secondary water interaction. The current 1/T-1 FDA approved contrast agents are all Gadolinium (Gd) based. Their contrast enhancement in the primary cardiovascular system is merely satisfactory and severely limited by the short retention time of these compounds in the subject. Thus, the development of Gd-based 1/T-1 contrast agents, with greater contrast enhancement or increased retention times, is the basis for this research collaboration. Current research has yielded the synthesis of a novel Gd-, Calix-arene compound which can potentially interact with human serum albumin through electrostatic interactions, leading to increased retention times in the cardiovascular system for more in depth imaging by MRI. Thorough characterization of this new synthetic product, and all synthetic steps leading to it, has been accomplished. Future work includes insertion of Gd, stability testing and relaxation measurements to determine the compounds potential as an imaging agent. While progress continues on the development of the calix-arene compound and the successful insertion of gadolinium, further characterization of iron oxide T2 imaging agents, currently used in cell labeling, was completed. Superparamagnetic Iron Oxide (SPIO) nanoparticles, either modified or in combination with other macromolecules, are being used for magnetic labeling of stem cells and other cells to monitor cell trafficking by Magnetic Resonance Imaging (MRI) in experimental models. The correlation of histology to MRI depends on the ability to detect SPIO labeled cells using Prussian blue (PB) stain and fluorescent tags to cell surface markers. Exposure of PB positive sections to ultraviolet light at a wavelength of 365 nanometers commonly used in fluorescence microscopy can result in color transformation of PB positive material from blue to brown. Although this color transformation is primarily an artifact that may occur during fluorescence microscopy, when the color transformation occurs of PB weakly positive cells and when this is used in combination with image processing, the detection of low levels of iron labeled cells in tissues samples can be correlated to cellular MRI.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Measurement Of Cytokines In Cervical Fluids
Archival Blood Spots. Cerebral Palsy and Autism Studies
Development Of An Ultrasensitive Capillary Electrophores
Development Of An Acupuncture/Microdialysis Needle
国内基金
海外基金
NGQDs/BiO2-x/PANI新型复合光催化剂的构筑及其可见光催化还原Cr(VI)的性能与机制研究
  • 批准号:
    2026JJ80226
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    唐新德
  • 依托单位:
骨胶原(Bio-Oss Collagen)联合龈下喷砂+骨皮质切开术治疗 根分叉病变的临床疗效研究
  • 批准号:
    2024JJ9542
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    潘涛华
  • 依托单位:
基于通用型 M13-Bio 噬菌体信号放大的动态 光散射免疫传感检测平台的建立及机制研究
  • 批准号:
    Q24C200014
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    湛胜楠
  • 依托单位:
智能双栅调控InSe Bio-FET可控构筑与原位细胞传感机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
  • 依托单位: